Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Long-Term Deferred Tax (2012 - 2013)

Biolife Solutions (BLFS) reported Long-Term Deferred Tax of $9.6 million for Q4 2013, up 3.7% year-over-year from $9.2 million in Q4 2012, and up 3.7% on a QoQ basis from $9.2 million in Q4 2012.

Biolife Solutions (BLFS) has 2 years of Long-Term Deferred Tax data on file, last reported at $9.6 million in Q4 2013.

  • Quarterly Long-Term Deferred Tax rose 3.7% year-over-year to $9.6 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $9.6 million (up 3.7% YoY) and the FY2013 annual result came in at $9.6 million, up 3.7% from the prior year.
  • Long-Term Deferred Tax rose to $9.6 million in Q4 2013 per BLFS's latest filing, from $9.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $9.6 million in Q4 2013 and bottomed at $9.2 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2013 9.59 Mn
Dec 31, 2012 9.24 Mn